Seeking Clues to Alnylam (ALNY) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics

Wall Street analysts forecast that Alnylam Pharmaceuticals (ALNY) will report quarterly loss of $0.56 per share in its upcoming release, pointing to a year-over-year decline of 250$588.18 million, exhibiting an increase of 19% compared to the year-ago quarter.The consensus EPS estimate for the quarter has undergone a downward revision of 4.6% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have re ...